CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Pre-funded warrant	Common Stock	Common Stock Pre-funded warrant	Additional Paid-In Capital	Additional Paid-In Capital Pre-funded warrant	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2023	$ 273,285		$ 5		$ 708,706		$ 8	$ (435,434)
Beginning Balance, Shares at Dec. 31, 2023			49,181,295
Issuance of common stock upon exercise of stock options	578	$ 225,073			578	$ 225,071
Issuance of common stock upon exercise of stock options, Shares			128,671	21,010,000
Issuance of common stock, net of issuance costs				$ 2
Issuance of common stock upon vesting of restricted stock units, Shares			133,595
Share-based compensation expense	4,368				4,368
Unrealized loss on investments	(135)						(135)
Net loss	(29,518)							(29,518)
Ending Balance at Mar. 31, 2024	473,651		$ 7		938,723		(127)	(464,952)
Ending Balance, Shares at Mar. 31, 2024			70,453,561
Beginning Balance at Dec. 31, 2024	407,976		$ 7		951,519		674	(544,224)
Beginning Balance, Shares at Dec. 31, 2024			70,645,139
Issuance of common stock upon vesting of restricted stock units, Shares			312,415
Share-based compensation expense	2,834				2,834
Unrealized loss on investments	(22)						(22)
Net loss	(31,983)							(31,983)
Ending Balance at Mar. 31, 2025	$ 378,805		$ 7		$ 954,353		$ 652	$ (576,207)
Ending Balance, Shares at Mar. 31, 2025			70,957,554